Innovative industry leader
BD Diabetes Care
The #1 selling pen needles just got even better
BD Nano™ 2nd Gen Pen Needles allow easy, more comfortable injections from start to finish.
Reference:
1. IQVIA XPT Device TRx Jun 19-May 20.
2. Whooley S, Briskin T, Gibney MA, et al. Evaluating the User Performance and Experience with a Re-Engineered 4 mm x 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles. Diabetes Ther. 2019;10(2):697-712.
BD Nano™ 2nd Gen Pen Needles
Redesigned with patients in mind. Easier injections from start to finish
Wider outer cover that makes it easier to attach to the pen injection device
Larger, green, inner needle shield that’s easier to grip and remove before the patient injects
Comfortable, contoured needle base that helps patients hold the pen against their skin, without wobbling, also providing a more reliable injection
Existing proven benefits of BD Ultra-Fine™ PentaPoint™ Comfort and EasyFlow™ Technology
BD Nano™ 2nd Gen Pen Needles contoured needle base provides greater comfort and compensates for injection force variability, supporting more reliable subcutaneous injections.
Patients can update their injection experience to a contoured needle base.
* 226 patients with diabetes on insulin treatment were studied with a 150 mm visual analog scale (mean scores of >0 mm; clinically significant difference of ≥5 mm). BD Nano™ 2nd Gen demonstrated superiority vs. all comparator groups combined for overall ease of use. [(P <0.05)(Mean 19.9 mm, 95% CI, +13.8 to +25.9 mm)]
** Compared to other pen needles studied.
^ Reliability results from swine studies showing insulin under the skin.
† 1188 injections administered in swine across a range of injection forces using 20 μl of iodinated contrast delivered with BD Nano™ 2nd Gen vs. three 4mm posted hub pen needles. Measurements were obtained via fluoroscopic imaging. BD Nano™ 2nd Gen more closely achieved the 4 mm target injection depth with less variability (P =0.006).
The advantages of patient-preferred BD Nano™ 2nd Gen Pen Needles:
Bringing Real Value to Patients
Ergonomic design provides more comfortable injection experience
Compatible with widely used pen injection devices
Covered by most health plans at the preferred copay, including Medicare Part D.
Patient brochure features a “Try a Free Box” offer
* 226 patients with diabetes on insulin treatment were studied with a 150 mm visual analog scale (mean scores of >0 mm; clinically significant difference of ≥5 mm). BD Nano™ 2nd Gen demonstrated superiority vs. all comparator groups combined for feeling more comfortable throughout injection experience and for overall ease of use. [Comfort (P <0.05) (Mean +18.0 mm, 95% CI, +11.6 to +24.3 mm)]; [Easier (P <0.05)(Mean 19.9 mm, 95% CI, +13.8 to +25.9 mm)].
References:
1. Whooley S, Briskin T, Gibney MA, et al. Evaluating the User Performance and Experience with a Re-Engineered 4 mm x 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles. Diabetes Ther. 2019;10(2):697-712.
2. Rini C, Roberts BC, Morel D, et al. Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection. J Diabetes Sci Technol. 2019;13(3):533-545.
3. BD Compatibility Confirmation for Pen Needles and Pen Injector Manufacturers, Document Number: 149OTH-0004¬-20, Rev P, Dated 07 February 2021.
Pharmacists are positioned to give patients the diabetes training they need.
Your Patients Need to Know
people with diabetes in the US who are treated with insulin.
per year.
On average, they see a pharmacist over
Frequent pharmacy visits offer a unique opportunity for pharmacists to engage and educate patients.
Get your BD Patient Counseling Toolbox with free patient samples (to order, see link at end of this feature).
Consider recommending BD Nano™ 2nd Gen Pen Needles.
Inform your patients that they can download the free BD™ Diabetes Care App by texting
“BD Diabetes” to 31996.
References:
1. American Diabetes Association. Fast facts: Data and statistics about diabetes. Accessed February 2020 at https://professional.diabetes.org/sites/professional.diabetes.org/files/media/sci_2020_diabetes_fast_facts_sheet_final.pdf
2. Moose, J.; Branham, A. Pharmacists as Influencers of Patient Adherence. Pharmacy Times. 21 August 2014
Functional package design for all BD insulin syringes and pen needles is just another way that BD can help support correct product identification in the pharmacy at the point of sale.
Distinct, bold color coding and large, prominent numbers to identify pen needle lengths
Distinct bold color coding by insulin syringe barrel capacity and prominent, bold numbers identify needle lengths
Watch Video
LEARN MORE
2
The updated design of BD Nano™ 2nd Gen Pen Needles includes the following patented features:
6.8 million
There are nearly
3-4X
On average, they see an endocrinologist only
per year.
35X
Consider recommending BD Nano™ 2nd Gen Pen Needles to help make a difference in the lives of patients with diabetes.
Join the Movement …
Prominent Packaging
To place an order:
Use NDC/HRI #: 08290-3205-50
To learn more:
Visit our website.
Click here to order:
BD Patient Counseling Toolbox
With free patient samples
4,5
2,3,**,^
2
2
2
2
1
3,†
3
Back to top
Regulatory NDC/HRI #: 08290-3205-50
References:
1. Whooley S, et al. Diabetes Ther. 2019; doi: 10.1007/s13300-019-0585-7.
2. Whooley S, Briskin T, Gibney MA, et al. Evaluating the User Performance and Experience with a Re-Engineered 4 mm x 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles. Diabetes Ther. 2019;10(2):697-712.
3. Rini C, Roberts BC, Morel D, et al. Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection. J Diabetes Sci Technol. 2019;13(3):533-545, and doi: 10.1177/1932296819836987.
4. Aronson R et al. Clin. Therap. 2013;35(7):923–933.
5. Hirsch L, et al. Jrnl of Diab. Sci. and Tech. 2012;6(2):328–335.
U.S. Patent Nos. D787054, D825749, D804023 and other patents pending.
NDC/HRI #: 08290-3205-50
Patients rate them easier to use, from attachment to disposal, compared to other pen needles studied
A pen needle patients can trust for a more reliable injection depth
To help your patients learn more, click to view
BD Nano™ 2nd Gen Pen Needles patient brochure
1,*
2
SCAN ME
1
Reference:
1. IQVIA XPT Device TRx Jun 19-May 20.
2. Whooley S, Briskin T, Gibney MA, et al. Evaluating the User Performance and Experience with a Re-Engineered 4 mm x 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles. Diabetes Ther. 2019;10(2):697-712.
1,*
1,*
1,*
Trust BD to continue providing diabetes injection device solutions.
BD Insulin Syringes available in all barrel capacities (0.3ml, 0.5ml and 1ml) and needle lengths